{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T22:35:13Z","timestamp":1784068513445,"version":"3.55.0"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100006229","name":"Oak Ridge Institute for Science and Education","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006229","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virology"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.virol.2017.05.010","type":"journal-article","created":{"date-parts":[[2017,5,29]],"date-time":"2017-05-29T14:47:04Z","timestamp":1496069224000},"page":"164-169","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Stockpiled pre-pandemic H5N1 influenza virus vaccines with AS03 adjuvant provide cross-protection from H5N2 clade 2.3.4.4 virus challenge in ferrets"],"prefix":"10.1016","volume":"508","author":[{"given":"Xiangjie","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica A.","family":"Belser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna A.","family":"Pulit-Penaloza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah M.","family":"Creager","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhu","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stacie N.","family":"Jefferson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian A.","family":"York","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Stevens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taronna R.","family":"Maines","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel B.","family":"Jernigan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline M.","family":"Katz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min Z.","family":"Levine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terrence M.","family":"Tumpey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.virol.2017.05.010_bib1","doi-asserted-by":"crossref","first-page":"e1401","DOI":"10.1371\/journal.pone.0001401","article-title":"Cross-protection against lethal H5N1 challenge in ferrets with an adjuvanted pandemic influenza vaccine","volume":"3","author":"Baras","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.virol.2017.05.010_bib2","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.virusres.2013.05.006","article-title":"H5N1 vaccines in humans","volume":"178","author":"Baz","year":"2013","journal-title":"Virus Res"},{"key":"10.1016\/j.virol.2017.05.010_bib3","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1056\/NEJMra052211","article-title":"Avian influenza A (H5N1) infection in humans","volume":"353","author":"Beigel","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.virol.2017.05.010_bib4","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1093\/infdis\/jiq093","article-title":"Safety and immunogenicity of influenza A H5 subunit vaccines: effect of vaccine schedule and antigenic variant","volume":"203","author":"Belshe","year":"2011","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.virol.2017.05.010_bib5","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1001\/jama.2014.12609","article-title":"Immunogenicity of avian influenza A\/Anhui\/01\/2005(H5N1) vaccine with MF59 adjuvant: a randomized clinical trial","volume":"312","author":"Belshe","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.virol.2017.05.010_bib6","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1016\/S0140-6736(06)68656-X","article-title":"Safety and immunogenicity of an inactivated split-virion influenza A\/Vietnam\/1194\/2004 (H5N1) vaccine: phase I randomised trial","volume":"367","author":"Bresson","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.virol.2017.05.010_bib7","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1128\/CVI.00509-09","article-title":"Flexible label-free quantitative assay for antibodies to influenza virus hemagglutinins","volume":"17","author":"Carney","year":"2010","journal-title":"Clin. Vaccin. Immunol."},{"key":"10.1016\/j.virol.2017.05.010_bib8","series-title":"Biosafety in microbiological and medical laboratories","author":"Chosewood LC","year":"2009"},{"key":"10.1016\/j.virol.2017.05.010_bib9","doi-asserted-by":"crossref","first-page":"7962","DOI":"10.1073\/pnas.0903181106","article-title":"Fast rise of broadly cross-reactive antibodies after boosting long-lived human memory B cells primed by an MF59 adjuvanted prepandemic vaccine","volume":"106","author":"Galli","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.virol.2017.05.010_bib10","doi-asserted-by":"crossref","first-page":"e95496","DOI":"10.1371\/journal.pone.0095496","article-title":"Heterologous prime-boost vaccination with MF59-adjuvanted H5 vaccines promotes antibody affinity maturation towards the hemagglutinin HA1 domain and broad H5N1 cross-clade neutralization","volume":"9","author":"Khurana","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.virol.2017.05.010_bib11","doi-asserted-by":"crossref","first-page":"9033","DOI":"10.1073\/pnas.1608853113","article-title":"The enigma of the apparent disappearance of Eurasian highly pathogenic H5 clade 2.3.4.4 influenza A viruses in North American waterfowl","volume":"113","author":"Krauss","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.virol.2017.05.010_bib12","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.virusres.2011.07.003","article-title":"Genetic characterization and pathogenicity assessment of highly pathogenic H5N1 avian influenza viruses isolated from migratory wild birds in 2011, South Korea","volume":"160","author":"Kwon","year":"2011","journal-title":"Virus Res"},{"key":"10.1016\/j.virol.2017.05.010_bib13","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1086\/652701","article-title":"Safety and cross-reactive immunogenicity of candidate AS03-adjuvanted prepandemic H5N1 influenza vaccines: a randomized controlled phase 1\/2 trial in adults","volume":"201","author":"Langley","year":"2010","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.virol.2017.05.010_bib14","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.3201\/eid2207.160048","article-title":"Highly pathogenic avian influenza viruses and generation of novel reassortants, United States, 2014\u20132015","volume":"22","author":"Lee","year":"2016","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.virol.2017.05.010_bib15","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1517\/14712590903066695","article-title":"Prepandemic H5N1 influenza vaccine adjuvanted with AS03: a review of the pre-clinical and clinical data","volume":"9","author":"Leroux-Roels","year":"2009","journal-title":"Expert Opin. Biol. Ther."},{"key":"10.1016\/j.virol.2017.05.010_bib16","doi-asserted-by":"crossref","first-page":"e1665","DOI":"10.1371\/journal.pone.0001665","article-title":"Broad Clade 2 cross-reactive immunity induced by an adjuvanted clade 1 rH5N1 pandemic influenza vaccine","volume":"3","author":"Leroux-Roels","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.virol.2017.05.010_bib17","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/S0140-6736(07)61297-5","article-title":"Antigen sparing and cross-reactive immunity with an adjuvanted rH5N1 prototype pandemic influenza vaccine: a randomised controlled trial","volume":"370","author":"Leroux-Roels","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.virol.2017.05.010_bib18","doi-asserted-by":"crossref","DOI":"10.1093\/infdis\/jix001","article-title":"Cross-reactive antibody responses to novel H5Nx Influenza viruses Following homologous and heterologous prime boost vaccination with a pre-pandemic Stockpiled A(H5N1) vaccine in humans","author":"Levine","year":"2017","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.virol.2017.05.010_bib19","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1086\/507709","article-title":"Cross-protectiveness and immunogenicity of influenza A\/Duck\/Singapore\/3\/97(H5) vaccines against infection with A\/Vietnam\/1203\/04(H5N1) virus in ferrets","volume":"194","author":"Lipatov","year":"2006","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.virol.2017.05.010_bib20","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.coi.2009.05.016","article-title":"Heterologous prime-boost vaccination","volume":"21","author":"Lu","year":"2009","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.virol.2017.05.010_bib21","doi-asserted-by":"crossref","first-page":"5393","DOI":"10.1016\/j.vaccine.2008.07.084","article-title":"H5N1 VLP vaccine induced protection in ferrets against lethal challenge with highly pathogenic H5N1 influenza viruses","volume":"26","author":"Mahmood","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.virol.2017.05.010_bib22","doi-asserted-by":"crossref","first-page":"11788","DOI":"10.1128\/JVI.79.18.11788-11800.2005","article-title":"Avian influenza (H5N1) viruses isolated from humans in Asia in 2004 exhibit increased virulence in mammals","volume":"79","author":"Maines","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2017.05.010_bib23","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1016\/j.vaccine.2011.01.011","article-title":"Adjuvant system AS03 containing alpha-tocopherol modulates innate immune response and leads to improved adaptive immunity","volume":"29","author":"Morel","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.virol.2017.05.010_bib24","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1016\/S0140-6736(00)05066-2","article-title":"Safety and antigenicity of non-adjuvanted and MF59-adjuvanted influenza A\/Duck\/Singapore\/97 (H5N3) vaccine: a randomised trial of two potential vaccines against H5N1 influenza","volume":"357","author":"Nicholson","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.virol.2017.05.010_bib25","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.virol.2016.08.010","article-title":"Cross-protective efficacies of highly-pathogenic avian influenza H5N1 vaccines against a recent H5N8 virus","volume":"498","author":"Park","year":"2016","journal-title":"Virology"},{"key":"10.1016\/j.virol.2017.05.010_bib26","doi-asserted-by":"crossref","first-page":"7118","DOI":"10.1128\/JVI.00674-12","article-title":"Seasonal trivalent inactivated influenza vaccine protects against 1918 Spanish influenza virus infection in ferrets","volume":"86","author":"Pearce","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2017.05.010_bib27","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1093\/oxfordjournals.bmb.a071545","article-title":"Determinants of immunity to influenza infection in man","volume":"35","author":"Potter","year":"1979","journal-title":"Br. Med Bull."},{"key":"10.1016\/j.virol.2017.05.010_bib28","doi-asserted-by":"crossref","first-page":"10286","DOI":"10.1128\/JVI.01438-15","article-title":"Pathogenesis and Transmission of Novel Highly Pathogenic Avian Influenza H5N2 and H5N8 Viruses in Ferrets and Mice","volume":"89","author":"Pulit-Penaloza","year":"2015","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2017.05.010_bib29","first-page":"493","article-title":"A simple method of estimating fifty percent endpoints","volume":"27","author":"Reed","year":"1938","journal-title":"J. Hyg."},{"key":"10.1016\/j.virol.2017.05.010_bib30","unstructured":"SAGE Working Group on Influenza Vaccines and Immunizations, 2013. Influenza A (H5N1) Vaccine Stockpile and Inter-Pandemic Vaccine Use."},{"key":"10.1016\/j.virol.2017.05.010_bib31","doi-asserted-by":"crossref","first-page":"8888","DOI":"10.1016\/j.vaccine.2011.09.069","article-title":"Vaccination with drifted variants of avian H5 hemagglutinin protein elicits a broadened antibody response that is protective against challenge with homologous or drifted live H5 influenza virus","volume":"29","author":"Santiago","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.virol.2017.05.010_bib32","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1002\/jat.3130","article-title":"Non-clinical safety and biodistribution of AS03-adjuvanted inactivated pandemic influenza vaccines","volume":"35","author":"Segal","year":"2015","journal-title":"J. Appl. Toxicol."},{"key":"10.1016\/j.virol.2017.05.010_bib33","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.3201\/eid2208.160146","article-title":"Novel Reassortant Avian Influenza A(H5N6) Viruses in Humans, Guangdong, China, 2015","volume":"22","author":"Shen","year":"2016","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.virol.2017.05.010_bib34","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1016\/S0264-410X(02)00632-1","article-title":"Boosting immunity to influenza H5N1 with MF59-adjuvanted H5N3 A\/Duck\/Singapore\/97 vaccine in a primed human population","volume":"21","author":"Stephenson","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.virol.2017.05.010_bib35","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1126\/science.1124513","article-title":"Structure and receptor specificity of the hemagglutinin from an H5N1 influenza virus","volume":"312","author":"Stevens","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.virol.2017.05.010_bib36","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1056\/NEJMoa040419","article-title":"Avian influenza A (H5N1) in 10 patients in Vietnam","volume":"350","author":"Tran","year":"2004","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.virol.2017.05.010_bib37","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1086\/600035","article-title":"Human infection with highly pathogenic avian influenza A (H5N1) virus: review of clinical issues","volume":"49","author":"Uyeki","year":"2009","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.virol.2017.05.010_bib38","doi-asserted-by":"crossref","first-page":"2174","DOI":"10.1056\/NEJMp068205","article-title":"H5N1 influenza--continuing evolution and spread","volume":"355","author":"Webster","year":"2006","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.virol.2017.05.010_bib39","unstructured":"WHO, 2011. Manual for the laboratory diagnosis and virological surveillance of influenza."},{"key":"10.1016\/j.virol.2017.05.010_bib40","unstructured":"WHO, 2016a. Cumulative number of confirmed human cases of avian influenza A(H5N1) reported to WHO."},{"key":"10.1016\/j.virol.2017.05.010_bib41","unstructured":"WHO, 2016b. Human infection with avian influenza A(H5N6) virus \u2013 China."},{"issue":"Suppl 5","key":"10.1016\/j.virol.2017.05.010_bib42","doi-asserted-by":"crossref","first-page":"B40","DOI":"10.1016\/S0264-410X(02)00509-1","article-title":"Selection of influenza vaccine strains and developing pandemic vaccines","volume":"20","author":"Wood","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.virol.2017.05.010_bib43","doi-asserted-by":"crossref","first-page":"5770","DOI":"10.1128\/JVI.00180-16","article-title":"Molecular Characterizations of Surface Proteins Hemagglutinin and Neuraminidase from Recent H5Nx Avian Influenza Viruses","volume":"90","author":"Yang","year":"2016","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2017.05.010_bib44","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1056\/NEJMc1502983","article-title":"Human Infection with a Novel Avian Influenza A(H5N6) Virus","volume":"373","author":"Yang","year":"2015","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.virol.2017.05.010_bib45","article-title":"Antibody-dependent cell-mediated cytotoxicity to Hemagglutinin of Influenza A viruses After Influenza vaccination in humans. open Forum","volume":"3","author":"Zhong","year":"2016","journal-title":"Infect. Dis."}],"container-title":["Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682217301599?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682217301599?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T00:42:13Z","timestamp":1758588133000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0042682217301599"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":45,"alternative-id":["S0042682217301599"],"URL":"https:\/\/doi.org\/10.1016\/j.virol.2017.05.010","relation":{},"ISSN":["0042-6822"],"issn-type":[{"value":"0042-6822","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Stockpiled pre-pandemic H5N1 influenza virus vaccines with AS03 adjuvant provide cross-protection from H5N2 clade 2.3.4.4 virus challenge in ferrets","name":"articletitle","label":"Article Title"},{"value":"Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virol.2017.05.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}